Pharmaceutical Sector
Coverage of Pharmaceutical Sector in the Nexus archive.
- Funding option: royalties giant opens Hong Kong base as mainland China biotech deals surge
The world’s largest biopharmaceutical royalties buyer has established its first Asia-Pacific base in Hong Kong as mainland Chinese biotech firms drive record out-licensing deals. Royalty financing is highlighted as an alternative capital-raising method amid US investment restrictions.
- From Sick Care to Healthcare
Hong Kong is recalibrating its role in the regional healthcare landscape as Merck Healthcare Hong Kong & Macau's Tony Cheng emphasizes prevention over profit in pharma. The pharmaceutical sector faces complex transitions due to regional competition, shifting patient flows, and technological changes.
- Bernstein's Liang on China's Edge in Pharma Sector
The article discusses China's competitive advantages in the pharmaceutical sector as analyzed by Bernstein's Liang. It highlights factors contributing to China's growing influence in drug development and production.